03737.HK
Zhongzhi Pharmaceutical Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 0.74
+5.71%Year over year
Reported trailing growth
- Revenue
- -11.3%
- EBITDA
- -62.1%
- EBIT
- -80.5%
- EPS
- -86.3%
- Free cash flow
- -12.7%
- Operating cash flow
- -61.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.6%
- EBITDA
- -28.9%
- EBIT
- -64.1%
- Net income
- -45.4%
- EPS
- -46.0%
- Free cash flow
- -29.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026